# Pharmacokinetics and Pharmacodynamics of Topiramate for Weight Loss in Youth: PHARMATOP

> **NCT04986631** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 62 (actual)

## Conditions studied

- Obesity, Childhood

## Interventions

- **DRUG:** Topiramate Tablets

## Key facts

- **NCT ID:** NCT04986631
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-04
- **Primary completion:** 2024-09-26
- **Final completion:** 2024-09-26
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04986631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04986631, "Pharmacokinetics and Pharmacodynamics of Topiramate for Weight Loss in Youth: PHARMATOP". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04986631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*